Related Experiment Video
Updated: Feb 28, 2026

11:35
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
58.8K
Using a multidimensional unfolding approach to assess multiple sclerosis patient preferences for disease-modifying
Angel Perez Sempere1, Vanesa Vera-Lopez2, Juana Gimenez-Martinez1
1Department of Neurology, Hospital General Universitario de Alicante, Alicante.
Patient Preference and Adherence
|June 16, 2017
Summary
Relapsing-remitting multiple sclerosis patients prioritize disease progression and relapse prevention when choosing therapies. Multidimensional unfolding is a viable method for understanding these patient preferences for disease-modifying therapies.
Area of Science:
- Neurology
- Health Services Research
- Psychometrics
Background:
- Multidimensional unfolding (MDU) is a multivariate technique for preference assessment.
- MDU uses a geometric model to map individuals and alternatives in a shared space.
- This method is effective even with small sample sizes.
Purpose of the Study:
- To assess patient preferences for disease-modifying therapy (DMT) attributes in relapsing-remitting multiple sclerosis (RRMS).
- To utilize multidimensional unfolding (MDU) for preference evaluation in RRMS patients.
Main Methods:
- A cross-sectional pilot study involving RRMS patients.
- Key DMT attributes evaluated: relapse prevention, disease progression prevention, side-effect risk, and administration route/schedule.
- Patient preferences were assessed using a five-card game, ranking attributes from 1 (most preferred) to 5 (least preferred).
Main Results:
- 37 RRMS patients participated (mean age 38.6, 78.4% female).
- Disease progression prevention (51.4%) and relapse prevention (40.5%) were the most critical attributes.
- Administration frequency was least preferred by 56.8% of patients; 19.6% considered side-effect risk of low importance.
Conclusions:
- Patient preferences for DMT attributes are crucial for shared decision-making.
- Efficacy attributes (progression and relapse prevention) are paramount for RRMS patients.
- MDU is a feasible method for assessing multiple sclerosis patient preferences, warranting further research with stated choice methods.

